SCHEMBL9681415

SCHEMBL9681415

CCOC(=O)CCCSc1nc2nc(Cl)ccc2n1Cc1ccc(Br)cc1F

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 4/20 0.43
MAPT P10636 2/20 0.37
TBXA2R P21731 2/20 0.37
TRAP1 Q12931 3/20 0.36
HSP90B1 P14625 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX5AP P20292 5/20 0.35
AKR1A1 P14550 1/20 0.35
AKR1B1 P15121 1/20 0.35
HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683456 0.88 CTSG (0.42) TBXA2RTRAP1HSP90B1AKR1A1AKR1B1
SCHEMBL9701302 0.87 PTGDR2 (0.45) PTGDR2MAPTTBXA2RTRAP1HSP90B1
SCHEMBL9681413 0.75 TBXA2R (0.41) MAPTTBXA2RTRAP1HSP90B1ALOX5AP
SCHEMBL9701533 0.74 CTSG (0.42) MAPTTBXA2RTRAP1HSP90B1AKR1A1
SCHEMBL16334449 0.70 CYP1A2 (0.40) PTGDR2MAPTALDH1A1
SCHEMBL30350667 0.70 CYP1A2 (0.40) PTGDR2MAPTALDH1A1
SCHEMBL9581575 0.70 TBXA2R (0.58) PTGDR2TBXA2R
SCHEMBL9682042 0.70 PTGDR2 (0.53) PTGDR2TBXA2RALDH1A1
SCHEMBL9699191 0.70 PTGDR2 (0.66) PTGDR2TBXA2R
SCHEMBL7033870 0.68 PTGDR2 (0.54) PTGDR2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5128359-A Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation LABORATOIRES UPSA (FR) 1992-07-07 US disclosed
US-5021443-A Noval benzimidazole and azabenzimiazole derivatives which are thromboxane receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present LABORATOIRES UPSA (FR) 1991-06-04 US disclosed